Mitigating compliance risk and enhancing commercial capabilities across a multi-market distributor network

Data-driven distributor selection for a specialized oncology portfolio market entry

Using local hospital data to prevent a mandatory price cut for a cardiovascular drug

Cost-minimization analysis to optimize net price strategy for an oncology biologic in KSA

Developing a budget impact model to support the listing of a novel GLP-1 in the UAE

Developing a cost-offset model to communicate the value of a therapy for the treatment of patients with chronic migraine

Developing a HTA ready cost effectiveness model for atopic dermatitis in KSA

Understanding the HPV Vaccine Funding Landscape in Sub-Saharan Africa

Navigating the market landscape for advanced molecular diagnostics in AMR Management

Understanding the impact of clinical trial design on the market potential for a SMA Product

Mapping Saudi Arabia’s Laboratory Landscape for Cardiovascular Testing

Understanding the treatment affordability of high-cost SCD therapies in Egypt, India, Nigeria and Pakistan

Understanding the Therapeutic Landscape and Treatment of SCD in Sub-Saharan Africa

Gaining an understanding of the reimbursement landscape and access potential for a new treatment for the treatment of migraine

To understand the current and expected future treatment landscape of wet age-related macular degeneration (AMD) in KSA

Understanding the obesity market in Saudi Arabia

Understand the applicable PMA pathways for PKD & Thalassemia across the GCC markets and assess the commercial potential for a new product

Assessing sickle cell and thalassemia patient profile and treatment paradigm in the Saudi Market

Understanding current treatment approach for generalized Myasthenia Gravis (gMG) and assess the perceived value of a new product among neurologists

Understanding current treatment approach for a rare disorder and assessing the perceived value, evidence package and its price potential of a new product

Evaluation of treatment and public funding landscape for Duchenne Muscular Dystrophy (DMD) in Algeria, Tunisia, and Morocco

Assessment of the Value Perception of two PCV-20 pediatric vaccines and its P&MA outcomes in Public and Private Market

Research study to support HPV vaccine manufacturer in understanding the value perception and price potential of their product in a Private Market setting

Evaluating Healthcare Policies and Possible Funding Pathways for CAR-T Therapies in KSA

Assessment of a Medical Device to be Used During Liver Transplants

Developing and Updating Client Market Access Strategy for GCC Markets

Understanding the Perception Around FOC Programs Preferred by Payers for SCD Products in the GCC

Conducting a Market Research Study to Understand the P&MA Outcomes of the Drug Indicated for Prurigo Nodularis (PN)

Understanding the Types of Information Used by Physicians when Learning about and Prescribing New Treatments for Thyroid Eye Disease

Landscape Assessment of Tenders Across the GCC Region

Development of Launch Strategy for Cystic Fibrosis Products

Strategic Assessment of the Multiple Sclerosis Market to Define Price and Access Potential for 4 Innovators in Emerging Markets Including South Africa

Conducting a Market Research Study to Understand the Pricing and Market Access Scenarios for a New Treatment Indicated for Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)

UAE Hospitals and Laboratories Market Landscape Assessment

Conducting a Market Research Study to Support the Development of the Market Access Strategy of a Pneumococcal Vaccine (PCV)

Understanding how to Implement a Named Patient Program for Alzheimer’s Disease in the GCC

Conducting a Secondary Research Study to Understand the Genomic Approaches being used by the Key Companies in Scope for NASH and T2DM

In-depth Analysis of New Products in Multiple Sclerosis to Understand Product Positioning and Associate Product Potential in Key MEA Geographies

Developed Strategies and Solutions to Support the Sales team to Optimize the Launch of a Diagnostic Test

Understanding Risks for Biosimilars in the MEA Region, and Associated Entry List and Net Prices

Conducting an In-depth Review on the Perceptions of a COVID-19 Diagnostic Test

Stakeholder Engagement Planning for a Novel Breast Cancer Product

Assessing Oncology Portfolio Offering Feasibility in the MEA Region

Conjoint Analysis Assessment for Payer and Physician Pricing and Access Decision Making Drivers in Rheumatoid Arthritis

Understanding Feasibility of Innovative Contracting in Kuwait, India and Nigeria

Conducting a Market Research Study to Understand the P&R Landscape for a New CAR-T Product in KSA

Determining the Access Challenges and Price Potential of a Direct-Acting Oral Anticoagulant

Mock Negotiation Workshop to Aid Distributor in Payer Engagement

Assessing the Value Perception and Market Access Potential of a Haemophilia Drug

Pricing and Market Access Strategy for a Haematology Product in the GCC

Localising a health economic model for a respiratory diagnostic test manufacturer

Conducting a Market Research Study to Understand the Cost Implication and Potential Benefits of the Introduction of an IPV-containing Hexavalent Vaccine to the Childhood Vaccine Schedule

Conducting a Market Research Study to Understand the Perceptions of Introducing a new Diabetes and Obesity Drug

Developed Public Sector Risk Assessment for MERS during Hajj Season in Saudi Arabia

Pricing and Market Access Strategy for a Haematology Product in the GCC

Market Research Study to Understand the P&R Landscape for a New CAR-T Product in KSA

Conjoint Analysis Assessment for Payor & Physician Pricing and Access Decision Making Drivers in Rheumatoid Arthritis

Understanding the Feasibility of Innovative Contracting in Kuwait, and Nigeria

Assessing Oncology Portfolio Offering Feasibility in the MEA Region

Defining the price potential and market access strategy for a new SCD therapy launching in the GCC

Understanding the Patient Journey for a Gene Therapy within Haemophilia

Development of a Pricing Strategy for Opioid Addiction Products

Understanding the Price Potential and Market Access Strategy to Successfully Launch in the GCC Market

Consolidate Understanding from Mock Payer Negotiations Workshop

Assessing the Value Perception and Market Access Potential of a Haemophilia Drug